A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(18 sites)
China
Beijing Anzhen Hospital of Capital Medical University, Beijing, Beijing Municipality Beijing Luhe Hospital, Capital Medical Univeristy, Beijing, Beijing Municipality Beijing Tsinghua Changgeng Hospital, Beijing, Beijing Municipality Fuwai Hospital, CAMS & PUMC, Beijing, Beijing Municipality Guangdong Provincial People's Hospital, Guangzhou, Guangdong Shijiazhuang People's Hospital, Shijiazhuang, Hebei Daqingshi People's Hospital, Daqing, Heilingjiang The 2nd Xiangya Hospital of Central South University, Changsha, Hunan The Third Xiangya Hospital of Central South University, Changsha, Hunan Nanchang People's Hospital, Nanchang, Jiangxi Binzhou Medical University Hospital, Binzhou, Shandong Heze Municipal Hospital, Heze, Shandong Qilu Hospital of Shandong University, Jinan, Shandong Zibo Municipal Hospital, Zibo, Shandong West China Hospital of Sichuan University, Chengdu, Sichuan Tianjin People's Hospital, Tianjin, Tianjin Municipality The First Affiliated Hospital of Wenzhou Medical Univesity, Wenzhou, Zhejiang Peking University First Hospital, Beijing Last updated February 2025